JKJapleen Kaur

Japleen Kaur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Japleen Kaur has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Capturing Behavioral Symptoms in Huntington's Disease Using the Huntington's Disease‐Behavioral Questionnaire

    by Siena Rigatuso, Krisha Bagga, Shelby Hughes, Japleen Kaur, Paul E. Gilbert, Jody Corey‐Bloom

    Background: The Huntington's Disease Behavioral Questionnaire (HD‐BQ) captures behavioral symptoms arising from cognitive, psychiatric, and functional domains. Recognizing the high prevalence of anosognosia in HD, the HD‐BQ incorporates patient‐ and companion‐reported versions. Objective: Examine the utility of the HD‐BQ in capturing behavioral symptoms in HD. Methods: The HD‐BQ was administered to 71 manifest HD patients and their companions, plus 71 healthy controls (HC). Differences in HD‐BQ scores were examined using Mann–Whitney U and Wilcoxon signed‐ranks tests. Results: HD patients reported more severe behavioral symptoms than HC ( p < 0.001). Companions reported more widespread and severe symptoms than patients ( Z = −3.7, p < 0.001). The largest discrepancies were observed for cognitive items—difficulty shifting thoughts or activities ( p < 0.001), concentrating ( p = 0.002), keeping track of commitments ( p = 0.006), judgment ( p = 0.004), and indecisiveness ( p = 0.022). Conclusions: The HD‐BQ captures a wide range of behavioral disturbances in HD. Companions consistently reported more frequent and severe symptoms than patients, likely reflecting patients’ anosognosia.


  • Open Access

    Development and Validation of a Brief Fall Questionnaire ( FALL ‐ HD ) for Patients with Huntington's Disease

    by Japleen Kaur, Deng‐Yuan Liou, Krisha Bagga, Nadeen Youhanan, Andrew Hall, Paul E. Gilbert, Daniel J. Goble, Jody Corey‐Bloom

    Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutation in the huntingtin gene on chromosome 4, leading to progressive cognitive decline, motor impairment, and functional disability. Falls represent the leading cause of nursing home placement in HD. Despite the significant clinical implications, validated instruments for fall assessment, including fall frequency, are lacking in HD. Objectives: To construct and evaluate the psychometric properties of a questionnaire for assessing fall status, including fall frequency, in ambulatory patients with HD. Methods: We developed a concise 3‐item questionnaire based on a comprehensive literature review and initial pilot study. We evaluated the responses of 107 HD gene‐positive participants in the main study. Reliability (test–retest, internal consistency) and validity (criterion, convergent, divergent) were assessed. Results: The FALL‐HD Questionnaire demonstrated reliability with a test–retest correlation coefficient of r = 0.85 and an internal consistency (Cronbach's alpha) of 0.71. Convergent validity was established using Spearman correlations with the UHDRS Total Motor Score ( r = 0.75, p < 0.001), Total Maximal Chorea Score ( r = 0.65, p < 0.001), and Total Functional Capacity ( r = 0.53, p < 0.001), in addition to Total Body Sway (TBS, r = 0.62, p < 0.001), a measure of postural stability from the BTrackS™ Balance System. Using ROC curves, the FALL‐HD outperformed (AUC = 0.90) existing measures of balance such as the Total Body Sway (AUC = 0.85), Chair Sit‐to‐Stand Test (AUC = 0.65) and Timed Up and Go (AUC = 0.58). Conclusions: The FALL‐HD is a brief, valid and reliable, screening instrument of fall status, including fall frequency, in ambulatory patients with HD.


  • Open Access

    Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum

    by Japleen Kaur, Nadeen Youhanan, Krisha Bagga, Andrew Hall, Paul E. Gilbert, Daniel J. Goble, Jody Corey‐Bloom

    Background: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutation in the huntingtin gene on chromosome 4, leading to progressive cognitive decline, motor impairment, and functional disability. Although balance impairment is recognized in HD, its onset and evolution with disease stage remain poorly understood. Objective: The aim was to track the onset and evolution of balance impairment in HD with progression of disease stage using the BTrackS Balance Plate. Methods: Total body sway (TBS) was assessed in 123 gene‐positive participants and 33 healthy controls (HC) using the BTrackS Balance Plate and laptop software. The prognostic index–derived Huntington's Disease Integrated Staging System (HD‐ISS) was used to stratify these subjects into stage 0/1 (n = 51), stage 2 (n = 38), and Stage 3 (n = 34). Nonparametric receiver operating characteristic curve analysis was used to compute optimal cutoff values for TBS. Results: Balance assessment revealed significant differences in TBS between HCs and gene‐positive participants ( P < 0.001). TBS varied significantly across disease stages ( P < 0.001), with mean values of 9.56 cm (stage 0/1), 14.46 cm (stage 2), and 28.26 cm (Stage 3). The comparison between HCs and stage 0/1 individuals revealed strong discrimination (area under the curve [AUC] = 0.709), with a threshold of 7.72 cm achieving 74.5% sensitivity. The most robust discrimination emerged between stage 2 and Stage 3 participants (AUC = 0.71), with a threshold of 11.85 cm at 82.4% sensitivity. Conclusions: In conclusion, this cross‐sectional study demonstrates that balance impairment is an early and progressive feature of HD, detectable even before the onset of overt motor symptoms.


  • Open Access

    How Early Does Anosognosia Begin in Huntington's Disease?

    by Krisha Bagga, Allen Xu, Andrew Hall, Japleen Kaur, Paul E. Gilbert, Jody Corey‐Bloom

    Background: Individuals with Huntington's disease (HD) commonly experience anosognosia, a lack of awareness of disease‐specific deficits. However, how early anosognosia begins in the course of HD remains unclear. Objective: To characterize the onset of anosognosia in HD by exploring its presence/absence at various stages of disease. Methods: The Anosognosia Scale was given to 60 gene carriers (stratified by the HD Integrated Staging System (HD‐ISS), Total Functional Capacity (TFC), CAG‐Age‐Product (CAP), and composite UHDRS (cUHDRS) score) as well as their study partners. Differences between informant and patient scores of ≥6 points were considered evidence of anosognosia. Results: 18% of participants in HD‐ISS stage 0/1, 22% with TFC = 13, 37% who would be eligible for clinical trials (CAP score 400–500), and 23% with a cUHDRS ≥14 displayed anosognosia. Conclusions: We conclude that anosognosia appears early in HD. This lack of awareness should dissuade against over‐reliance on self‐report instruments in HD clinical research.


  • Open Access

    Weekend Effect and Predictors of Mortality for Patients Presenting to Emergency Department with COVID-19 Infection

    by Amteshwar Singh, Jerome Gnanaraj, Evani Jain, Japleen Kaur, Waseem Khaliq

    Background: Weekend presentation to the emergency department (ED) has been associated with increased morbidity and mortality in various clinical settings. However, the literature is scant whether such an effect exists for patients presenting with COVID-19 infection. Additionally, comparative analyses of mortality predictors in COVID-19 patients evaluated at the emergency department need further exploration. Methods: This retrospective cohort study examined factors associated with mortality among adult patients (aged ≥ 18 years) who presented with COVID-19 to the emergency departments of five hospitals within the Johns Hopkins Health System (combined capacity: 2513 beds) between March 1 and 4 May 2020. Data were extracted from electronic health records. Multivariable logistic regression was utilized to assess the relationship between mortality and a range of variables, including sociodemographic characteristics, clinical presentation, laboratory parameters, pre-existing comorbidities, and weekend versus weekday presentation. Results: Of the 2767 patients, 685 (25%) presented to the emergency department on weekends. Compared to weekday presenters, weekend patients were more likely to be hospitalized (64%), and these patients had a mean symptom duration of 5 days (SD ± 6). Weekend presenters also exhibited higher rates of clinical frailty, dehydration, hypoxia, and respiratory distress upon arrival. In multivariable logistic regression analysis adjusting for sociodemographic characteristics, clinical risk factors, and laboratory findings, independent predictors of increased mortality included absence of a primary care provider (OR 3.47; 95% CI: 2.37–5.07), peripheral oxygen saturation (SpO2) < 95% at presentation (OR 1.46; 95% CI: 1.001–2.12), and hyperglycemia (OR 2.13; 95% CI: 1.25–3.65). Notably, the presence of crackles on physical examination demonstrated a trend toward reduced mortality (OR 0.47; 95% CI: 0.24–0.92). Conclusions: While weekend presentation was associated with higher hospitalization rates among patients with COVID-19, it did not independently predict increased mortality. Absence of a primary care provider, hypoxia, and hyperglycemia at presentation emerged as strong, independent predictors of mortality in the ED setting. Race, gender, and obesity were not significantly associated with mortality in this cohort, warranting further investigation. These findings may support more effective triage and risk stratification strategies in current and future public health emergencies.


  • Open Access

    Dysphagia in Huntington's Disease: An Evaluation of Swallowing Disturbance across the HD ‐ ISS Staging Spectrum

    by Japleen Kaur, Krisha Bagga, Paul E. Gilbert, Jody Corey‐Bloom

    Background: The onset and pattern of progression of swallowing impairment in HD remain poorly understood. The Swallowing Disturbance Questionnaire (SDQ) has proven useful in assessing dysphagia across various neurological conditions, but its use in HD remains largely unexplored. Objectives: To evaluate swallowing difficulties in HD using the SDQ and Huntington's Disease Integrated Staging System. Methods: The SDQ was administered to 87 gene positive subjects stratified into HD‐ISS Stages 0/1 ( n = 27), 2 ( n = 21), and 3 ( n = 39). Kruskal‐Wallis was used to compare performance among cohorts and partial eta‐squared ( η 2 ) was used to calculate effect sizes. Spearman's rho ( r ) was used to calculate correlations. Results: Total swallowing disturbance score significantly differed across HD‐ISS stages ( ηp 2 = 0.20, p < 0.001), with similar trends and strong effect sizes for both oral ( ηp 2 = 0.15, p < 0.001) and pharyngeal ( ηp 2 = 0.12, p < 0.001) phases. Within cohorts, total swallowing disturbance score was significantly different between Stages 0/1 and 2 ( p = 0.007), Stage 2 and 3 ( p = 0.02) and between Stages 0/1 and 3 ( p < 0.001). Using quartile‐based severity cut‐points (Mild: 0–6, Moderate: 7–14, Severe: >14), 92.6% Stage 0/1 related mild swallowing problems, 7.4% of Stage 0/1 reporting moderate difficulties. In Stage 2, 28.5% described moderate and over 25% reported severe issues. Among Stage 3 subjects, one‐third reported moderate and almost half experienced severe swallowing difficulties. Conclusions: Swallowing disturbances emerge early and progressively worsen across the HD‐ISS staging spectrum, with both oral and pharyngeal phases affected. These findings suggest that early assessment of swallowing function is warranted in HD clinical care.